X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.420
0.00 (0.00%)
At close: Dec 24, 2025, 4:00 PM EST
4.350
-0.070 (-1.58%)
Pre-market: Dec 26, 2025, 7:00 AM EST
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $386.47 million as of December 26, 2025. Its market cap has increased by 329.26% in one year.
Market Cap
386.47M
Enterprise Value
341.63M
1-Year Change
329.26%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $386.47M, an increase of 279.74%. That is a compound annual growth rate of 21.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 386.47M | 208.90% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |